Travere Therapeutics, Inc.
TVTX· Nasdaq
TVTXTravere Therapeutics, Inc.
Source filing unavailable
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$3.53K | -$6.63K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR
